Rua Bioscience NZX:RUA:
SALES FOR Q1 FY26 ARE A RECORD
RENOUCENABLE RIGHTS ISSUE OF 1 NEW SHARES FOR EVERY 3 EXISTING SHARES TO RAISE UP TO NZ$2MILLION
ISSUE PRICE UNDER RIGHTS OFFER NZ$0.025 PER SHARE
Rua Bioscience Says Sales For Q1 FY26 Are A Record
Earlier from Rua Bioscience
- RUA: Revenue surged, losses narrowed, and a capital raise is planned to fund further growth
- RUA: FY25 revenue soared and losses narrowed, but further capital is needed to fuel global growth
- Rua Bioscience Says Co & Cann Reach Resolution In Legal Proceedings
- RUA: Revenue growth and narrowed loss offset by ongoing liquidity and going concern risks